Diabetes Discharge Transitional CGM Study (DDT-CGM) (DDT-CGM)
Diabetes Mellitus, Type 2
About this trial
This is an interventional prevention trial for Diabetes Mellitus, Type 2 focused on measuring hospital discharge, Continuous Glucose Monitoring, Type 2 diabetes, rehospitalization
Eligibility Criteria
Inclusion Criteria:
Type 2 diabetes plus one additional criteria during hospitalization:
A1C greater than or equal to 9, New diagnosis of diabetes Type 2 and A1C greater than or equal to 8, On insulin, On sulfonylurea, Deemed to by high risk by hospitalist staff for post-hospitalization complications, Acute Heart Failure, Acute Coronary Syndrome (ACS), Stroke, or a TIA.
-
Exclusion Criteria:
Type 1 Diabetes, or Not high risk (as above), or Already using a CGM, or Unable to understand or use a CGM, or Unable or unwilling to use a CGM, or Participating in another clinical trial within 30 days.
-
Sites / Locations
- Logan Regional Hospital
Arms of the Study
Arm 1
Arm 2
No Intervention
Active Comparator
Standard Care
Diabetic education and CGM monitoring
A blinded CGM will be placed to review glucoses after discharge in the Standard Care arm.
Treatment arm will get diabetic education, active CGM use with patient feedback for 14 days, active access to the PI for concerns relating to hospitalization. They will also receive a brief, 15 minute phone call from the PI on day 3-4, 6-7, 9-10 and day 14-15.